Financing Quarterly Statistics, Q4 2024
A Look At Financing Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, October-December 2024
During Q4, biopharmas brought in an aggregate $16.8bn in financing and device company fundraising totaled $2.3bn; while in vitro diagnostic firms and research tools players raised $294m.
